Stone House Investment Management, LLC Crispr Therapeutics Ag Transaction History

Stone House Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$44.62 - $62.75 $2,944 - $4,141	-66 Reduced 12.55%	460 $21,000
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $2,200 - $2,931	-43 Reduced 7.56%	526 $28,000
Q1 2024 May 15, 2024	BUY	$60.67 - $89.12 $24,268 - $35,648	400 Added 236.69%	569 $38,000
Q4 2023 Jan 30, 2024	SELL	$38.62 - $72.18 $1,042 - $1,948	-27 Reduced 13.78%	169 $10,000
Q1 2023 Apr 25, 2023	BUY	$41.0 - $56.12 $8,036 - $10,999	196 New	196 $8,000

494

64.3M

1.68M

1.95M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.88B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Stone House Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stone House Investment Management, LLC with notifications on news.